stockrowAgios Pharmaceuticals, Inc. (AGIO) vs Stoke Therapeutics, Inc. (STOK)
- Agios Pharmaceuticals, Inc. AGIO 29.41 +4.03%
- Stoke Therapeutics, Inc. STOK 26.54 +1.80%
Agios Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.7B and $1.7B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 214.4% against −86.3%. Agios Pharmaceuticals, Inc. has the higher net margin (−264.8% vs −862.1%) and the higher return on invested capital (−75.0% vs −482.0%). Across the 16 metrics below, Agios Pharmaceuticals, Inc. leads on 12 and Stoke Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | AGIO | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | 100.00% | 68.51% |
| Operating margin | (297.72%) | (913.12%) | 0.00% |
| Net margin | (264.76%) | (862.07%) | 0.00% |
| Free cash flow margin | (238.54%) | (764.66%) | 0.00% |
| Return on equity | (32.95%) | (73.62%) | (51.96%) |
| Return on assets | (30.44%) | (63.42%) | (46.06%) |
| Return on invested capital | (75.02%) | (482.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack